U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality
Powered by the Evidence-based Practice Centers
✓ Evidence Reports ✓ All of EHC
✓ Evidence Reports ✓ All of EHC

SHARE:

FacebookTwitterFacebookPrintShare

Chemotherapy in Advanced Colorectal Cancer

Research Report Apr 14, 2010

Findings from this study were published in the following journal articles.

  1. Sanoff HK, Carpenter WR, Stürmer T, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol 2012 Jun 4 [Epub ahead of print]. PMID: 22665536.
  2. Sanoff HK, Carpenter WR, Martin CF, et al. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst 2012 Feb 8;104(3):211-27. PMID: 22266473.
  3. Meyerhardt JA, Li L, Sanoff HK, et al. Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol 2012 Feb 20;30(6):608-15. PMI: 22253466.
  4. Sanoff HK, Carpenter WR, Freburger J, et al. Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis. Cancer 2012 Jan 31 [Epub ahead of print]. PMID: 22294436.

Project Timeline

Chemotherapy in Advanced Colorectal Cancer

Apr 14, 2010
Topic Initiated
Apr 14, 2010
Research Report
Page last reviewed November 2017
Page originally created November 2017

Internet Citation: Research Report: Chemotherapy in Advanced Colorectal Cancer. Content last reviewed November 2017. Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.
https://effectivehealthcare.ahrq.gov/products/colorectal-cancer/abstract

Select to copy citation